Student-athletes outfitted with wearables to help study COVID

A major collegiate athletic conference is teaming with a top-tier academic healthcare system and a popular fitness technology company to study the utility of wearables for preventing or monitoring COVID-19 and other infectious diseases in student-athletes.

The Pac-12 says it’s working with Stanford Medicine and Fitbit in a project that will run through the year and involve 1,000 volunteers from all 12 schools in the conference.

“While the study is specific to student-athletes, it may help to develop broader solutions to help people stay healthy and detect early signs of illness,” the Pac-12 notes in an announcement.

“Researchers hope that learnings from this young adult age group can be applied to larger populations and will add to the growing body of knowledge around the potential for wearables like Fitbit to help control the spread of illness, especially in higher-risk communal settings.”

Read the rest.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.